GlyProVac, born from Aarhus University, is pioneering vaccines to fight antibiotic resistance. Their breakthrough BEMAP method reveals how bacteria change their proteins, a key step for creating powerful vaccines. They're advancing GPV02, a vaccine candidate with the potential to protect against various E. coli infections.
Established in 2018.
